Highlights •Prognosis of ALK-positive NSCLC patients has dramatically improved over last decade. • Patients with ALK-positive NSCLC are at increased risk of coagulation disorders. • We reported a rapidly evolving DIC as presentation of ALK-positive NSCLC. • Admission to ICU should be considered for patients with ALK-positive NSCLC. • The association between ALK-rearrangement and VTE should be assessed prospectively.
Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter? / De Giglio A.; Porreca R.; Brambilla M.; Metro G.; Prosperi E.; Bellezza G.; Pirro M.; Chiari R.; Ricciuti B.. - In: THROMBOSIS RESEARCH. - ISSN 0049-3848. - ELETTRONICO. - 163:(2018), pp. 51-53. [10.1016/j.thromres.2017.12.004]
Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter?
De Giglio A.;Ricciuti B.
2018
Abstract
Highlights •Prognosis of ALK-positive NSCLC patients has dramatically improved over last decade. • Patients with ALK-positive NSCLC are at increased risk of coagulation disorders. • We reported a rapidly evolving DIC as presentation of ALK-positive NSCLC. • Admission to ICU should be considered for patients with ALK-positive NSCLC. • The association between ALK-rearrangement and VTE should be assessed prospectively.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
